These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24780498)

  • 1. Neuroprotective effects of leptin in the context of obesity and metabolic disorders.
    Davis C; Mudd J; Hawkins M
    Neurobiol Dis; 2014 Dec; 72 Pt A():61-71. PubMed ID: 24780498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides.
    Strnadová V; Pačesová A; Charvát V; Šmotková Z; Železná B; Kuneš J; Maletínská L
    Biosci Rep; 2024 Apr; 44(4):. PubMed ID: 38577975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, leptin, and Alzheimer's disease.
    Lee EB
    Ann N Y Acad Sci; 2011 Dec; 1243():15-29. PubMed ID: 22211890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented Insulin and Leptin Resistance of High Fat Diet-Fed APPswe/PS1dE9 Transgenic Mice Exacerbate Obesity and Glycemic Dysregulation.
    Lee YH; Hsu HC; Kao PC; Shiao YJ; Yeh SH; Shie FS; Hsu SM; Yeh CW; Liu HK; Yang SB; Tsay HJ
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.
    Maletínská L; Popelová A; Železná B; Bencze M; Kuneš J
    J Endocrinol; 2019 Feb; 240(2):R47-R72. PubMed ID: 30475219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease.
    Pérez-González R; Antequera D; Vargas T; Spuch C; Bolós M; Carro E
    J Alzheimers Dis; 2011; 24 Suppl 2():17-25. PubMed ID: 21335656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials.
    Signore AP; Zhang F; Weng Z; Gao Y; Chen J
    J Neurochem; 2008 Sep; 106(5):1977-90. PubMed ID: 18466320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt6 in pro-opiomelanocortin neurons controls energy metabolism by modulating leptin signaling.
    Tang Q; Gao Y; Liu Q; Yang X; Wu T; Huang C; Huang Y; Zhang J; Zhang Z; Li R; Pu S; Zhang G; Zhao Y; Zhou J; Huang H; Li Y; Jiang W; Chang Y; He J
    Mol Metab; 2020 Jul; 37():100994. PubMed ID: 32278654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin resistance and obesity in mice with deletion of methyl-CpG-binding protein 2 (MeCP2) in hypothalamic pro-opiomelanocortin (POMC) neurons.
    Wang X; Lacza Z; Sun YE; Han W
    Diabetologia; 2014 Jan; 57(1):236-45. PubMed ID: 24078059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term time-restricted feeding during the resting phase is sufficient to induce leptin resistance that contributes to development of obesity and metabolic disorders in mice.
    Oishi K; Hashimoto C
    Chronobiol Int; 2018 Oct; 35(11):1576-1594. PubMed ID: 30084652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal glucocorticoid signalling determines leptin resistance and obesity in aging mice.
    Henneicke H; Kim S; Swarbrick MM; Li J; Gasparini SJ; Thai J; Foong D; Cavanagh LL; Fong-Yee C; Karsten E; Lin RCY; Cooper MS; Zhou H; Seibel MJ
    Mol Metab; 2020 Dec; 42():101098. PubMed ID: 33045434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin: a link between ageing, metabolism and neurodegenerative disorders.
    Stoyanova II
    Neurobiol Dis; 2014 Dec; 72 Pt A():72-83. PubMed ID: 25173805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agrp-Specific Ablation of Scly Protects against Diet-Induced Obesity and Leptin Resistance.
    Torres DJ; Pitts MW; Hashimoto AC; Berry MJ
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31340540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance.
    Hwang M; Go Y; Park JH; Shin SK; Song SE; Oh BC; Im SS; Hwang I; Jeon YH; Lee IK; Seino S; Song DK
    Int J Obes (Lond); 2017 Feb; 41(2):279-288. PubMed ID: 27867203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies.
    McGuire MJ; Ishii M
    Cell Mol Neurobiol; 2016 Mar; 36(2):203-17. PubMed ID: 26993509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia.
    Zhang F; Wang S; Signore AP; Chen J
    Stroke; 2007 Aug; 38(8):2329-36. PubMed ID: 17600230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spontaneous leptin receptor point mutation causes obesity and differentially affects leptin signaling in hypothalamic nuclei resulting in metabolic dysfunctions distinct from db/db mice.
    Piattini F; Le Foll C; Kisielow J; Rosenwald E; Nielsen P; Lutz T; Schneider C; Kopf M
    Mol Metab; 2019 Jul; 25():131-141. PubMed ID: 31076350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of central leptin resistance in obesity.
    Jung CH; Kim MS
    Arch Pharm Res; 2013 Feb; 36(2):201-7. PubMed ID: 23359004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.